Current Guidelines for Heart Failure Management
A comprehensive review of the 2024 ACC/AHA guidelines, covering HFrEF and HFpEF classifications, pharmacological interventions, and device-based therapies.
Comprehensive, expert-reviewed coverage of clinical practice, pharmacology, diagnostics, public health, and emerging medical research. Verified by 12,000+ board-certified professionals.
A comprehensive review of the 2024 ACC/AHA guidelines, covering HFrEF and HFpEF classifications, pharmacological interventions, and device-based therapies.
Exploring the neuroinflammatory cascade, amyloid-beta clearance mechanisms, and the clinical implications of recent anti-amyloid monoclonal antibody trials.
Detailed breakdown of incretin hormone pathways, cardiorenal protective effects, and dosing considerations for semaglutide and tirzepatide in clinical practice.
Clinical strategies to overcome primary and acquired resistance to PD-1/PD-L1 inhibitors, including combination regimens and biomarker-driven approaches.
WHO surveillance data analysis, stewardship program frameworks, and policy interventions to mitigate the rise of multidrug-resistant pathogens worldwide.
Evidence-based screening protocols for autism spectrum disorder and global developmental delay, emphasizing family-centered care pathways.
Comparative outcomes of sleeve gastrectomy vs. Roux-en-Y gastric bypass, including metabolic improvements, complication rates, and nutritional management.
Integration of CBT, ACT, and pharmacological augmentation strategies. Review of rTMS and ketamine-assisted therapy clinical protocols.